[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Top tips for staying safe

Simple steps may help you avoid buying counterfeit medicines.

Check the packaging


  1. Familiarise yourself with every aspect of the packaging, the blister-pack (if there is one) and the medicine itself
  2. Each time you renew your prescription, compare the packaging against your previous pack. You are looking for even the tiniest difference in clarity of print, colour, seals, etc.
  3. Check that the medicine is in date and that the dosage is correct. Check that it has a patient information leaflet in the correct language
  4. If you notice any differences in appearance, report them to your pharmacist and your national regulator immediately (click here for a list of national regulators) 

 

Check the medicine

  1. Check carefully that it is consistent in colour and texture with your previous prescription.  Does it crumble now, or did it before? Does the colour differ from your normal medicine?
  2. Be aware of the medicine smelling or tasting differently
  3. Consider keeping a diary of effects or side effects. If your medicine does not seem to be working as normal or if you notice new (or absent) side effects, you must report these to your doctor as soon as possible.

The chance of you receiving a counterfeit medicine is relatively small, BUT counterfeiting incidents are increasing at a rapid rate. The internet is a very risky way of buying your medicines unless you can be sure that the online pharmacy is genuine. By checking your medicines on a regular basis, you can reduce the risk of taking a counterfeit medicine.


Did you know?

An international study in 2004 reported that 53% of artesunate (a vital anti-malarial substance) tablet packs sold in mainland south-east Asia did not contain any artesunate.

EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA